-
公开(公告)号：EP1555026A2
公开(公告)日：2005-07-20
申请号：EP05007256.0
申请日：2001-04-26
申请人： Breivogel, Boris
摘要： A method for chemical modification of mammalian blood comprising the steps of:
collecting blood from a mammal into a container having reduced internal pressure in presence of an anticoagulant, such as heparin (step 0)
maintaining an oxidative atmosphere, if necessary add an oxidizing agent (step 1a)
adding a diluent, preferably isotonic sterile saline (step 2a)
mix the so obtained fraction (step 4)
aging the fraction for a sufficient amount of time by storing the fraction (step 5) and
followed by a dilution step to a physiologically acceptable concentration. (step 9)摘要翻译： 一种用于哺乳动物来源的血液，包括以下步骤化学修饰法：从哺乳动物到容器中收集血液具有降低的内部压力在抗凝血剂的存在下，如肝素（步骤0）保持氧化性气氛中，如果必要的话添加氧化剂（ 步骤1a）中添加稀释剂，优选等渗无菌盐水（步骤2a）中混合如此获得的级分（步骤4）通过存储部分（步骤5老化充分的时间量的级分）和，接着稀释步骤，以生理 可接受的浓度 （步骤9）
-
公开(公告)号：EP1278530B1
公开(公告)日：2005-06-15
申请号：EP01943290.5
申请日：2001-04-26
申请人： Breivogel, Boris
发明人： BREIVOGEL, Boris , KIEF, Horst
CPC分类号： A61K35/14 , A61K33/40 , A61K35/22 , A61K2300/00
摘要： New methods for the chemical modification of mammal urine and mammal blood are disclosed for the treatment of diseases.
-
公开(公告)号：EP1278530A2
公开(公告)日：2003-01-29
申请号：EP01943290.5
申请日：2001-04-26
申请人： Breivogel, Boris
发明人： BREIVOGEL, Boris , KIEF, Horst
CPC分类号： A61K35/14 , A61K33/40 , A61K35/22 , A61K2300/00
摘要： New methods for the chemical modification of mammal urine and mammal blood are disclosed for the treatment of diseases.
-
公开(公告)号：EP1555026A3
公开(公告)日：2005-12-07
申请号：EP05007256.0
申请日：2001-04-26
申请人： Breivogel, Boris
摘要： A method for chemical modification of mammalian blood comprising the steps of:
collecting blood from a mammal into a container having reduced internal pressure in presence of an anticoagulant, such as heparin (step 0)
maintaining an oxidative atmosphere, if necessary add an oxidizing agent (step 1a)
adding a diluent, preferably isotonic sterile saline (step 2a)
mix the so obtained fraction (step 4)
aging the fraction for a sufficient amount of time by storing the fraction (step 5) and
followed by a dilution step to a physiologically acceptable concentration. (step 9)
-
-
-
搜索结果
4 条记录 (耗时 0.007 秒)
